Angelo Paolo Dei Tos Selected Research

Angelo Paolo Dei Tos Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 06/2007
25	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 09/2010
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2015
4	Liposarcoma 03/2021 - 09/2010
4	Leiomyosarcoma 07/2017 - 09/2010
3	Melanoma (Melanoma, Malignant) 05/2022 - 01/2021
3	Synovial Sarcoma (Synovioma) 03/2022 - 09/2010
3	Microsatellite Instability 01/2022 - 11/2019
3	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 01/2015
3	Disease Progression 01/2021 - 01/2013
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2017
3	Neutropenia 01/2019 - 01/2017
3	Hemangiosarcoma (Angiosarcoma) 07/2017 - 07/2009
3	Myxoid Liposarcoma 01/2017 - 07/2009
2	Margins of Excision 03/2022 - 10/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2009
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 07/2017
2	Carcinoma (Carcinomatosis) 01/2022 - 09/2013
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 02/2021
2	Adenocarcinoma 10/2021 - 01/2020
2	Chondroblastoma 09/2021 - 10/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 06/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2012
2	Adenosarcoma 11/2020 - 01/2018
2	Adenoma (Adenomas) 01/2020 - 09/2013
2	Carcinogenesis 01/2020 - 11/2012
2	Hypertension (High Blood Pressure) 01/2019 - 05/2012
2	Thrombocytopenia (Thrombopenia) 10/2018 - 01/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 01/2014
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018 - 01/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2014
2	Diabetic Foot 01/2018 - 01/2014
2	Giant Cell Tumor of Bone 10/2017 - 01/2016
2	Cysts 08/2008 - 02/2007
1	Skin Neoplasms (Skin Cancer) 05/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Cholangiocarcinoma 01/2022
1	COVID-19 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Papillary Thyroid Cancer 01/2022
1	Triploidy 12/2021
1	Stomach Neoplasms (Stomach Cancer) 10/2021
1	Osteoblastoma 09/2021
1	Lung Neoplasms (Lung Cancer) 06/2021
1	Bone Neoplasms (Bone Cancer) 06/2021
1	Lung Diseases (Lung Disease) 06/2021

Drug/Important Bio-Agent (IBA)

8	Ifosfamide FDA LinkGeneric 12/2021 - 12/2011
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
5	Biological ProductsIBA 01/2022 - 01/2011
5	TrabectedinIBA 03/2021 - 12/2011
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
4	Gemcitabine FDA Link 01/2020 - 01/2017
4	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2012
4	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 03/2012
3	AntibodiesIBA 03/2022 - 06/2007
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	AnthracyclinesIBA 12/2021 - 12/2011
3	Protein Isoforms (Isoforms)IBA 10/2021 - 10/2013
3	Immune Checkpoint InhibitorsIBA 05/2021 - 11/2019
3	Hormones (Hormone)IBA 01/2021 - 01/2019
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2013
3	Aquaporin 1IBA 07/2010 - 01/2006
2	Inosine Triphosphate (ITP)IBA 01/2022 - 02/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2021
2	CateninsIBA 09/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 07/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 07/2009
2	Anaplastic Lymphoma KinaseIBA 11/2020 - 07/2016
2	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2017
2	Vascular Endothelial Growth Factor CIBA 01/2020 - 07/2009
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2009
2	Alanine Transaminase (SGPT)IBA 01/2019 - 10/2018
2	Sunitinib (Sutent)FDA Link 06/2018 - 01/2018
2	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 01/2017
2	Coloring Agents (Dyes)IBA 09/2013 - 06/2007
2	Aquaporins (Water Channels)IBA 02/2007 - 01/2006
1	Vitamin D FDA LinkGeneric 05/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	Thrombopoietin ReceptorsIBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Protein CIBA 01/2022
1	AZD 6244IBA 12/2021
1	nilotinib FDA Link 12/2021
1	avapritinibIBA 12/2021
1	multidrug resistance-associated protein 1IBA 12/2021
1	ripretinibIBA 12/2021
1	Tight Junction ProteinsIBA 10/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2021
1	beta CateninIBA 09/2021

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2022 - 07/2009
15	Therapeutics 01/2022 - 09/2008
11	Radiotherapy 03/2022 - 12/2012
4	Neoadjuvant Therapy 01/2022 - 01/2017
2	Adjuvant Chemotherapy 01/2015 - 03/2012
1	Thymectomy 08/2021